Variant Creutzfeldt-Jakob disease: An update

Folia Neuropathologica

Volumn 50, Issue 1, 2012, Pages 50-56

  Ironside, James W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Blood; Plasma; Prion; Prion protein; Transfusion; Variant CJD

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; METHIONINE; PRION PROTEIN;

ASYMPTOMATIC INFECTION; BLOOD TESTIS BARRIER; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; CLINICAL TRIAL (TOPIC); CODON; ERYTHROCYTE; FAMILIAL CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GENETIC PREDISPOSITION; GENOTYPE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HEMOPHILIA; HOMOZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INCUBATION TIME; KURU; LYMPHOID TISSUE; MOUTH INFECTION; NONHUMAN; REVIEW; SPORADIC CREUTZFELDT JAKOB DISEASE; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE; VARIANT CREUTZFELDT JAKOB DISEASE AGENT; VIRUS DETECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 84860337641     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar H, van Duijn C, Will RG. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 1673-1674. (Pubitemid 29224526)
2. Amorfix detects vCJD prions in blood from non-human primates; http://www.analytica-world.com/news/e/108609/.
3. Brown P. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 2007; 13 (Suppl 5): 33-40. (Pubitemid 350253402)
4. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987; 37: 895-904. (Pubitemid 17081060)
5. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208-209. (Pubitemid 32718547)
6. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fra ser H, Bostock CJ. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501. (Pubitemid 27435325)
7. Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, Ritchie DL, Dabaghian R, Ambrose HE, Gill ON. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. Brit Med J 2009; 338: b1442.
8. Corporate update on vCJD test development; http://www.amorfix.com/pdf- press/pr-2010/2010-05-31-corporate-upda te-on-vCJD.pdf.
9. DH risk assessment for vCJD infectivity in blood products. Det Norske Veritas 2003; http://www.dnv.com/binaries/vCJD-Update-Report-tcm4-74414.pdf.
10. Edgeworth J, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS. Detection of prion infection in variant Creutzfeldt-Jakob disease: a bold-based assay. Lancet 2011; 377: 487-93.
11. Garske T, Ghani AC. Uncertainty in the tail of the variant Creutz - feldt-Jakob disease epidemic in the UK. PloS One 2010; 5: e15626.
12. Gregori L. A prototype assay to detect vCJD-infected blood. Lancet 2011; 377: 1-2.
13. Gregori L, McCombie N, Palmer D, Birch P, Sowemimo-Coker SO, Giulivi A, Rohwer RG. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform ence phalo pathies from blood. Lancet 2004; 364: 529-531. (Pubitemid 39070414)
14. Head MW, Yull H, Ritchie DL, Bishop MT, Ironside JW. Pathological investigation of the first donor and recipient pair linked by blood transfusion-associated variant Creutzfeldt-Jakob disease infection. Neuropathol Appl Neurobiol 2009; 35: 433-436.
15. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91: 221-230. (Pubitemid 44337279)
16. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733-739. (Pubitemid 38961558)
17. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, Sisó S, González L, Jeffrey M, Hunter N. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112: 4739-4520.
18. Ironside JW. Creutzfeldt-Jakob disease. Brain Pathol 1996; 6: 379-388.
19. Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110: 79-87. (Pubitemid 34289472)
20. Kaski D, Mead S, Hyare H, Cooper S, Jampana R, Overell J, Knight R, Collinge J, Rudge P. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374: 2128.
21. Lee CA, Ironside JW, Bell JE, Giangrande P, Ludlam C, Esiri MM, McLaughlin JE. Retrospective neuropathological review of prion disease in UK haemophilic patients. Thromb Haemost 1998; 80: 909-911. (Pubitemid 28556691)
22. Millar C, Connor N, Dolan G, Lee CA, Makris M, Wilde J, Win ter M, Ironside JW, Gill N, Hill FG. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with bleeding disorders. Haemophilia 2010; 16: 305-315.
23. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-9. (Pubitemid 39070413)
24. Peden A, McCardle L, Head MW, Love S, Ward HJ, Cousens SN, Keeling DM, Millar CM, Hill FG, Ironside JW. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16: 296-304.
25. Prusiner SB. Prions. Proc Nat Acad Sci USA 1998; 95: 13363-13383. (Pubitemid 28525623)
26. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144. (Pubitemid 12089840)
27. Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, DeArmond SJ, Prusiner SB. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 1999; 96: 15137-15142. (Pubitemid 30019778)
28. Smith PG, Bradley R. Bovine spongiform encephalopathy (BSE) and its epidemiology. Br Med Bull 2003; 66: 185-198. (Pubitemid 37173502)
29. Turner ML, Ironside JW. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Blood Rev 1998; 12: 255-268. (Pubitemid 29027576)
30. Turner ML, Ludlam CA. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Brit J Haematol 2008; 144: 14-23.
31. Variant CJD and blood products. Health Protection Agency 2004; http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPA web-C/1195733818681?p= 1191942152861.
32. WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. World Health Organisation 2000, Geneva.
33. Ward HJ, Everingtom D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, Heath C, Knight RS, Smith PG, Will RG. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59: 111-120. (Pubitemid 43042877)
34. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-925. (Pubitemid 26102546)
35. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J. Clinical presentation and pre-mortem diagnosis of Creutzfeldt-Jakob disease associated with blood transfusion. Lancet 2006; 368: 2061-2067. (Pubitemid 44855106)